IDR 990.0
(-1.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 105.27 Billion IDR | 13.42% |
2022 | 89.04 Billion IDR | -3.96% |
2021 | 92.72 Billion IDR | 32.42% |
2020 | 70.02 Billion IDR | -3.0% |
2019 | 72.18 Billion IDR | 0.22% |
2018 | 72.02 Billion IDR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 24.09 Billion IDR | -12.87% |
2024 Q3 | 24.41 Billion IDR | 32.66% |
2024 Q2 | 20.23 Billion IDR | -16.04% |
2023 Q2 | 26.9 Billion IDR | 0.58% |
2023 Q1 | 26.75 Billion IDR | 30.49% |
2023 FY | 100.99 Billion IDR | 13.42% |
2023 Q4 | 27.65 Billion IDR | -4.93% |
2023 Q3 | 29.09 Billion IDR | 8.12% |
2022 Q3 | 23.8 Billion IDR | 6.23% |
2022 Q2 | 22.4 Billion IDR | 0.32% |
2022 FY | 89.04 Billion IDR | -3.96% |
2022 Q1 | 22.33 Billion IDR | -36.83% |
2022 Q4 | 20.5 Billion IDR | -13.87% |
2021 Q1 | 17.96 Billion IDR | 0.26% |
2021 FY | 92.72 Billion IDR | 32.42% |
2021 Q4 | 35.35 Billion IDR | 59.29% |
2021 Q3 | 22.19 Billion IDR | 29.01% |
2021 Q2 | 17.2 Billion IDR | -4.22% |
2020 Q4 | 17.91 Billion IDR | 0.0% |
2020 FY | 70.02 Billion IDR | -3.0% |
2019 FY | 72.18 Billion IDR | 0.22% |
2018 FY | 72.02 Billion IDR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
PT Bundamedik Tbk | 463.16 Billion IDR | 77.272% |
PT Metro Healthcare Indonesia Tbk | 125.19 Billion IDR | 15.914% |
PT Medikaloka Hermina Tbk | 1043.54 Billion IDR | 89.912% |
PT Mitra Keluarga Karyasehat Tbk | 783.59 Billion IDR | 86.566% |
PT Murni Sadar Tbk | 224.61 Billion IDR | 53.132% |
PT Famon Awal Bros Sedaya Tbk | 293.68 Billion IDR | 64.155% |
PT Royal Prima Tbk | 75.23 Billion IDR | -39.919% |
PT Sarana Meditama Metropolitan Tbk | 393.56 Billion IDR | 73.252% |
PT Siloam International Hospitals Tbk | 2519.46 Billion IDR | 95.822% |
PT Sejahteraraya Anugrahjaya Tbk | 583.07 Billion IDR | 81.946% |